Lausanne
Switzerland
2
2020-03-05
2
2022-07-05
These are the the leading inventors for applications assigned to GENE PREDICTIS SA:
GENE PREDICTIS SA based in Lausanne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels
#2 | 2020-01-30 β Patent 11,535,894 granted on 2022-12-27Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism
154322 β